Page 22 - Mass General Brigham - Innovators Guide 1.1
P. 22
22 INNO V AT O RS GUIDE | M ASS GENERAL BRIGH AM
3
Enabling
3 collaboration
Sponsored Research Agreements
Collaborative innovation is core to advancing Collaboration with industry is essential for realizing the full benefits of
healthcare. Successful partnering between the breakthroughs of Mass General Brigham staff. Sponsored Research
academic and commercial entities combines the Agreements (SRA) are a foundational tool to enable industry-funded, pre-
clinical research. SRAs rely on hypothesis-driven research in furtherance
best of the public and private sectors. of the hospital’s medical and educational mission. It should be noted that
SRAs are not used for packaged services and consulting arrangements –
Mass General Brigham is strongly committed to enabling typically they are covered by Institutional Service and individual consulting
its faculty and facilities to be joined with industry to share agreements, respectively, both supported by the Office of General Counsel.
patient benefiting insights and capabilities. The following The more than 250 Mass General Brigham SRAs transacted annually
collaborative modes help achieve those outcomes. typically include a scope of work (determined by the innovators and
agreed to by the industry sponsor) and a budget compliant with hospital
policy. The budget must have department administration approval with the
appropriate overhead included. Indirect charges should be the same as
that used in NIH funded non-clinical projects.
After the scope of work and budget are agreed to by the industry sponsor
and the innovators, the SRA request is triaged by Innovation to confirm the
following requirements are met:
Screen shot for SRA
